2021
DOI: 10.1002/kjm2.12472
|View full text |Cite
|
Sign up to set email alerts
|

Diclofenac‐induced adverse drug reactions and hyperbilirubinemia caused by a variant gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…For example, glucuronidation activity toward the acetaminophen of p.Phe364Leu–UGT1A1A9 was 5.0% of the wild type and glucuronidation activity toward the 2‐amino‐5‐nitro‐4‐trifluoromethylphenol (a major metabolite of flutamide) of p.Tyr486Asp‐UGT1A6 was <1% of the wild type 77,78 . Therefore, the gene analysis of variations on common exons in patients who experience adverse effects of drugs can help determine the significance of the variations 77,79 …”
Section: Variation Status Of Ugt1a1 and Diseasesmentioning
confidence: 99%
“…For example, glucuronidation activity toward the acetaminophen of p.Phe364Leu–UGT1A1A9 was 5.0% of the wild type and glucuronidation activity toward the 2‐amino‐5‐nitro‐4‐trifluoromethylphenol (a major metabolite of flutamide) of p.Tyr486Asp‐UGT1A6 was <1% of the wild type 77,78 . Therefore, the gene analysis of variations on common exons in patients who experience adverse effects of drugs can help determine the significance of the variations 77,79 …”
Section: Variation Status Of Ugt1a1 and Diseasesmentioning
confidence: 99%